Malignant rhabdoid tumor mimicking hepatoblastoma: A case report and literature review

Pediatric and Developmental Pathology

Volumn 10, Issue 5, 2007, Pages 409-415

  Wagner, Lars M ^a   Garrett, Jennifer K ^a   Ballard, Edgar T ^a   Hill, D Ashley ^b   Perry, Arie ^b   Biegel, Jaclyn A ^c   Collins, Margaret H ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Extrarenal rhabdoid tumor; Hepatoblastoma; INI 1; Malignant rhabdoid tumor; Rhabdoid tumor of liver; t(6; 22)

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; INI1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CASE REPORT; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HEPATOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; RHABDOID TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMOSOMAL PROTEINS, NON-HISTONE; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; FEMALE; HEPATOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; PERITONEAL NEOPLASMS; PREGNANCY; PREMATURE BIRTH; RHABDOID TUMOR; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 35948990872     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/06-08-0155.1     Document Type: Article

References (36)

1. Darbari A, Sabin KM, Shapiro CN, et al. Epidemiology of primary hepatic malignancies in US children. Hepatology 2003;38:560-566.
2. Yuri T, Danbara N, Shikata N, et al. Malignant rhabdoid tumor of the liver: case report and literature review. Pathol Int 2004;54:623-629.
3. Gururangan S, Bowman LC, Parham DM, et al. Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide. Cancer 1993;71:2653-2659.
4. Gonzalez-Crussi F, Goldschmidt RA, Hsueh W, et al. Infantile sarcoma with intracytoplasmic filamentous inclusions: distinctive tumor of possible histiocytic origin. Cancer 1982;49:2365-2375.
5. Biegel JA, Tan L, Zhang F, et al. Alterations of the HSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002;8:3461-3467.
6. Katzenstein HM, Kletzel M, Reynolds M, et al. Metastatic malignant rhabdoid tumor of the liver treated with tandem high-dose therapy and autologous peripheral blood stem cell rescue. Med Pediatr Oncol 2003;40:199-201.
7. Hunt SJ, Anderson WD. Malignant rhabdoid tumor of the liver. A distinct clinicopathologic entity. Am J Clin Pathol 1990;94:645-648.
8. Parham DM, Peiper SC, Robicheaux G, et al. Malignant rhabdoid tumor of the liver. Evidence for epithelial differentiation. Arch Pathol Lab Med 1988;112:61-64.
9. Katzenstein HM, London WB, Douglass EC, et al. Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study. J Clin Oncol 2002;20:3438-3444.
10. Ortega JA, Douglass EC, Feusner JH, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 2000;18:2665-2675.
11. Perry A, Fuller CE, Judkins AR, et al. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Mod Pathol 2005;18:951-958.
12. Biegel JA. Molecular genetics of atypical teratoid/rhabdoid tumor. Neurosurg Focus 2006;20:E11.
13. Reynolds P, Urayama KY, Von Behren J, et al. Birth characteristics and hepatoblastoma risk in young children. Cancer 2004;100:1070-1076.
14. Yamaguchi H, Ishii E, Hayashida Y, et al. Mechanism of thrombocytosis in hepatoblastoma: a case report. Pediatr Hematol Oncol 1996;13:539-544.
15. Scheimberg I, Cullinane C, Kelsey A, et al. Primary hepatic malignant tumor with rhabdoid features. A histological, immunocytochemical, and electron microscopic study of four cases and a review of the literature. Am J Surg Pathol 1996;20:1394-1400.
16. von Schweinitz D, Gluer S, Mildenberger H. Liver tumors in neonates and very young infants: diagnostic pitfalls and therapeutic problems. Eur J Pediatr Surg 1995;5:72-76.
17. Papadakis V, Vlachopapadopoulou EA, Levine L. Rhabdoid tumor of the kidney with humoral hypercalcemia and parathyroid hormone-related protein production. Med Pediatr Oncol 1995;24:133-136.
18. Ross JA, Gurney JG. Hepatoblastoma incidence in the United States from 1973 to 1992. Med Pediatr Oncol 1998;30:141-142.
19. Ogino S, Ro TY, Redline RW. Malignant rhabdoid tumor: a phenotype? An entity? - a controversy revisited. Adv Anat Pathol 2000;7:181-190.
20. Cajaiba MM, Neves JI, Casarotti FF, et al. Hepatoblastomas and liver development: a study of cytokeratin immunoexpression in twenty-nine hepatoblastomas. Pediatr Dev Pathol 2006;9:196-202.
21. Hoot AC, Russo P, Judkins AR, et al. Immunohistochemical analysis of HSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol 2004;28:1485-1491.
22. Judkins AR, Mauger J, Ht A, et al. Immunohistochemical analysis of HSNF5/INI1 in pediatric central nervous system tumors. Am J Surg Pathol 2004;28:644-650.
23. Uno K, Takita J, Yokomori K, et al. Aberrations of the HSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors. Genes Chromosomes Cancer 2002;34:33-41.
24. Biegel JA. Cytogenetics and molecular genetics of childhood brain tumors. Neurooncol 1999;1:139-151.
25. Biegel JA, Rorke LB, Packer RJ, et al. Monosomy 22 in rhabdoid or atypical tumors of the brain. J Neurosurg 1990;73:710-714.
26. Bruch LA, Hill DA, Cai DX, et al. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors. Hum Pathol 2001;32:156-162.
27. Biegel JA, Zhou JY, Rorke LB, et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999;59:74-79.
28. Parham DM, Weeks DA, Beckwith JB. The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy. Am J Surg Pathol 1994;18:1010-1029.
29. Ho DM, Hsu CY, Wong TT, et al. Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma. Acta Neuropathol (Berl) 2000;99:482-488.
30. Rorke LB, Packer JB, Biegel JA. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 1996;85:56-65.
31. Burger PC, Yu IT, Tihan T, et al. Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. Am J Surg Pathol 1998;22:1083-1092.
32. Wagner L, Hill DA, Fuller C, et al. Treatment of metastatic rhabdoid tumor of the kidney. J Pediatr Hematol Oncol 2002;24:385-388.
33. Zimmerman MA, Goumnerova LC, Proctor M, et al. Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor. J Neurooncol 2005;72:77-84.
34. Sevenet N, Sheridan E, Amram D, et al. Constitutional mutations of the HSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 1999;65:1342-1348.
35. Janson K, Nedzi LA, David O, et al. Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation. Pediatr Blood Cancer 2006;47:279-284.
36. Taylor MD, Gokgoz N, Andrulis IL, et al. Familial posterior brain tumors of infancy secondary to germline mutation of the hSNF5 gene. Am J Hum Genet 2000;66:1403-1406.